Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
23.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.0201
|
0.028
|
0.025
|
0.025
|
0.028
|
0.028
|
|
|
426.90
|
8.00
|
0.0201
|
0.023
|
0.0251
|
0.0226
|
0.0251
|
0.0228
|
|
|
34.60
|
8.00
|
0.0156
|
0.0288
|
0.0212
|
0.021
|
0.029
|
0.0288
|
|
|
655.55
|
31.00
|
0.0201
|
0.08
|
0.0304
|
0.022
|
0.0338
|
0.029
|
|
|
1 038.54
|
23.00
|
0.0201
|
0.07
|
0.03
|
0.03
|
0.04
|
0.0385
|
|
|
405.32
|
8.00
|
0.0152
|
0.07
|
0.028101
|
0.028101
|
0.028101
|
0.028101
|
|
|
28.10
|
1.00
|
0.0152
|
0.07
|
0.033
|
0.029
|
0.033
|
0.0324
|
|
|
298.18
|
7.00
|
0.0263
|
0.03
|
0.03
|
0.0263
|
0.039
|
0.03
|
|
|
833.63
|
13.00
|
0.02
|
0.04
|
0.0249
|
0.0249
|
0.0385
|
0.0385
|
|
|
598.51
|
16.00
|
0.02
|
0.04
|
0.023
|
0.023
|
0.023
|
0.023
|
|
|
118.34
|
4.00
|
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).